Moreover, since dapagliflozin reduces the anaerobic glycolysis,36 main metabolism on activated neutrophils, and CD11B expression levels, might suggest a protective role against inflammation response on patients with obesity and HFpEF progression.37 This evidence concerns the gene ITGAM and obesity disorder.